Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia.
The use of electro-convulsive therapy (ECT) in adolescents is controversial, and few studies have been conducted to assess its efficacy and safety in this population. We report the case of a 19-year-old boy who received two series of ECT, one at 15 and another at 16, for intractable catatonic schizophrenia. Since the age of 17, he has required treatment combining clozapine and maintenance ECT. The course showed a sustained moderate improvement. The treatment permitted the patient to regain some autonomy with moderate adverse effects. ECT remains an uncommon treatment in adolescents, and the current case supports the view that it should not be banned in young people.
Consoli
Angèle
A
Department of Child and Adolescent Psychiatry, APHP, CNRS, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, 47-3 Bd de l'Hôpital, 75651, Paris Cedex 13, France.
Boulicot
Valérie
V
Cornic
Françoise
F
Fossati
Philippe
P
Barbeau
Martine
M
Cohen
David
D
D000293:Adolescent; D018686:Anesthetics, Intravenous / Q000008:administration & dosage; D004565:Electroconvulsive Therapy / Q000379:methods*; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000175:diagnosis / Q000209:etiology; D015742:Propofol / Q000008:administration & dosage; D012560:Schizophrenia, Catatonic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D055815:Young Adult
D018686:Anesthetics, Intravenous; D015742:Propofol